Description

Indolizine, Octahydro-3,7-Dimethyl-, (3R,7S,8As)-Rel- (9Ci) is a high-purity, stereochemically defined indolizine derivative, a class of compounds valued for their complex heterocyclic structure. This specific isomer is critical for advanced research and development in fine chemical synthesis, where precise molecular architecture dictates functional performance. It serves as a sophisticated building block or chiral intermediate for pharmaceutical chemists, agrochemical researchers, and material scientists working on novel active ingredients and functional molecules.

Application

• Pharmaceutical Intermediate: Serves as a key chiral scaffold in the research and synthesis of novel drug candidates, particularly for central nervous system (CNS) or anti-infective agents.
• Agrochemical Research: Used in developing advanced pesticides or herbicides where the indolizine core contributes to biological activity and selectivity.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct natural product analogs or other complex heterocyclic systems.
• Material Science Precursor: Investigated for the development of organic semiconductors, liquid crystals, or fluorescent dyes due to its rigid, fused-ring structure.
• Catalyst Ligand Development: Potential use as a precursor for chiral ligands in asymmetric catalysis, enabling the production of enantiomerically pure compounds.
• Academic & R&D Reference Standard: Provides a pure, well-characterized compound for mechanistic studies, method development, and educational purposes in synthetic chemistry.

Basic Information

Item	Detail
Product Name	Indolizine, Octahydro-3,7-Dimethyl-, (3R,7S,8As)-Rel- (9Ci)
CAS No.	695201-13-9
Molecular Formula	C12H21N
Molecular Weight	179.30 g/mol
Synonyms	(3R,7S,8aS)-Octahydro-3,7-dimethylindolizine; rel-(3R,7S,8aS)-Octahydro-3,7-dimethylindolizine; 3,7-Dimethyloctahydroindolizine; Octahydro-3,7-dimethylindolizine (rel-(3R,7S,8aS)-form); Indolizine, octahydro-3,7-dimethyl-, (3R,7S,8aS)-rel-; 695201-13-9; (3R,7S,8aS)-3,7-Dimethyloctahydroindolizine
EINECS	Contact for details

Quality Control

Every batch of Indolizine, Octahydro-3,7-Dimethyl-, (3R,7S,8As)-Rel- (9Ci) is produced and analyzed under strict quality management protocols. Our products undergo rigorous quality testing, including chiral purity analysis, to ensure compliance with exacting R&D and process chemistry standards. A comprehensive Certificate of Analysis (COA) detailing identity, purity (by GC/HPLC), chiral excess, and impurity profile is provided with each shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from strong oxidizing agents. For long-term storage under inert atmosphere, please contact our technical team for specific recommendations.

Specification

Item	Specification
Appearance	Colorless to pale yellow liquid
Identification (IR)	Conforms to structure
Purity (GC/HPLC)	≥ 97.0% (Area %)
Chiral Purity (Chiral GC/HPLC)	≥ 98.0% de (diastereomeric excess)
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.